Kohlberg Kravis Roberts & Co’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-413,086	Closed	-$4.14M	–	216
2022 Q3	$4.14M	Hold	413,086	–	–	0.08%	53
2022 Q2	$4.08M	Buy	413,086 +82,744	+25%	+$817K	0.05%	62
2022 Q1	$3.26M	Buy	+330,342	New	+$3.24M	0.03%	80

Kohlberg Kravis Roberts & Co's LUXA Position: Q4 2022 in Review

Kohlberg Kravis Roberts & Co sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 413,086 shares — an estimated $4.14M sold.

Kohlberg Kravis Roberts & Co first reported a position in LUXA in Q1 2022 and held it in 3 quarters. The position peaked at $4.14M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Kohlberg Kravis Roberts & Co reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Kohlberg Kravis Roberts & Co sold 413,086 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.14M.
Kohlberg Kravis Roberts & Co first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
Kohlberg Kravis Roberts & Co's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $4.14M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2022, filed 14 Feb 2023.